Barbara Siegele
About
In The Last Decade
Barbara Siegele
10 papers receiving 332 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 162
- Cancer Research 135
- Oncology 86
- Clinical Biochemistry 65
- Immunology 49
Countries citing papers authored by Barbara Siegele
This map shows the geographic impact of Barbara Siegele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Siegele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Siegele more than expected).
Fields of papers citing papers by Barbara Siegele
This network shows the impact of papers produced by Barbara Siegele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Siegele. The network helps show where Barbara Siegele may publish in the future.
Co-authorship network of co-authors of Barbara Siegele
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Siegele. A scholar is included among the top collaborators of Barbara Siegele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Siegele. Barbara Siegele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 37 | |
| 2 | Relevance of histone marks H3K9me3 and H4K20me3 in cancer. | 52 |
| 3 | 68 | |
| 4 | Methodological and preanalytical evaluation of a RAGE immunoassay. | 46 |
| 5 | Apoptosis-related biomarkers sFAS, MIF, ICAM-1 and PAI-1 in serum of breast cancer patients undergoing neoadjuvant chemotherapy. | 25 |
| 6 | 93 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 21 | |
| 13 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.